IMMUTEP Ltd SEC filings IMMP

IMMUTEP Ltd has 739 filings in SEC EDGAR's recent list, going back to Feb 13, 2012. Its latest annual report, Form 20-F, was filed on Oct 23, 2026 for the period ended Jun 30, 2026. The most recent current report (Form 6-K) was filed on Nov 2, 2026. The company's fiscal year ends on June 30.

Form Description Filed Period
3 Initial insider ownership Apr 16, 2026 Mar 18, 2026
3 Initial insider ownership Apr 13, 2026 Mar 18, 2026
3 Initial insider ownership Apr 13, 2026 Mar 18, 2026
3 Initial insider ownership Apr 7, 2026 Mar 18, 2026
3 Initial insider ownership Apr 1, 2026 Mar 18, 2026
3 Initial insider ownership Apr 1, 2026 Mar 18, 2026
3 Initial insider ownership Apr 1, 2026 Mar 18, 2026
3 Initial insider ownership Apr 1, 2026 Mar 18, 2026
SC 13G/A Amended ownership over 5% (passive) Nov 12, 2024 —
SC 13G/A Amended ownership over 5% (passive) Feb 9, 2024 —
SC 13G/A Amended ownership over 5% (passive) Feb 9, 2023 —
SC 13G Ownership over 5% (passive) Feb 9, 2022 —
SC 13G/A Amended ownership over 5% (passive) Feb 11, 2021 —
SC 13G/A Amended ownership over 5% (passive) Feb 14, 2020 —
SC 13G Ownership over 5% (passive) Jun 5, 2015 —

Showing 15 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
IMMP (Nasdaq), PRRUF (OTC)
Fiscal year ends
June 30
Incorporated in
Australia
Headquarters
Sydney,, Australia
SEC filer status
Accelerated filer
SEC CIK
1506184
Former names
Prima BioMed Ltd (until Dec 1, 2017)

Other Pharmaceutical Preparations companies

All 570 Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.